Literature DB >> 14749878

[Apoptosis as a pathomechanism in sepsis].

S U Weber1, J-C Schewe, C Putensen, F Stüber, S Schröder.   

Abstract

Sepsis is still a leading cause of death in many intensive care patients. The pathophysiology of the disease is dominated by complex immune cascades. Recent research demonstrates that immune cells respond to sepsis with an increased rate of programmed cell death. Up-regulated apoptosis of leukocytes was observed in animal models of sepsis as well as in patients suffering from severe sepsis. The mitochondrial protein Bcl-2 and the caspase cascade play an important role in the regulation of apoptosis. Overexpression of Bcl-2 or inhibition of caspases resulted in an increased survival in animal models of sepsis. Recent reports indicate the relevance of apoptosis in patients with severe sepsis. These results may spawn novel immunomodulatory strategies in the treatment of sepsis.

Entities:  

Mesh:

Year:  2004        PMID: 14749878     DOI: 10.1007/s00101-003-0627-3

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  70 in total

1.  Neither Fas ligand nor endotoxin is responsible for inducible peritoneal phagocyte apoptosis during sepsis/peritonitis.

Authors:  C S Chung; G Y Song; L L Moldawer; I H Chaudry; A Ayala
Journal:  J Surg Res       Date:  2000-06-15       Impact factor: 2.192

2.  Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans.

Authors:  R S Hotchkiss; K W Tinsley; P E Swanson; R E Schmieg; J J Hui; K C Chang; D F Osborne; B D Freeman; J P Cobb; T G Buchman; I E Karl
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

3.  Caspases -2, -3, -6, and -9, but not caspase-1, are activated in sepsis-induced thymocyte apoptosis.

Authors:  K W Tinsley; S L Cheng; T G Buchman; K C Chang; J J Hui; P E Swanson; I E Karl; R S Hotchkiss
Journal:  Shock       Date:  2000-01       Impact factor: 3.454

Review 4.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

5.  Increased susceptibility to apoptosis in circulating lymphocytes of critically ill patients.

Authors:  S Schroeder; C Lindemann; D Decker; S Klaschik; R Hering; C Putensen; A Hoeft; A von Ruecker; F Stüber
Journal:  Langenbecks Arch Surg       Date:  2001-02       Impact factor: 3.445

6.  Sepsis-induced apoptosis of the thymocytes in mice.

Authors:  S D Wang; K J Huang; Y S Lin; H Y Lei
Journal:  J Immunol       Date:  1994-05-15       Impact factor: 5.422

Review 7.  Considering immunomodulatory therapies in the septic patient: should apoptosis be a potential therapeutic target?

Authors:  A Oberholzer; C Oberholzer; R M Minter; L L Moldawer
Journal:  Immunol Lett       Date:  2001-01-15       Impact factor: 3.685

8.  Hemorrhagic shock-induced bacterial translocation is reduced by xanthine oxidase inhibition or inactivation.

Authors:  E A Deitch; W Bridges; J Baker; J W Ma; L Ma; M B Grisham; D N Granger; R D Specian; R Berg
Journal:  Surgery       Date:  1988-08       Impact factor: 3.982

9.  Differential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediators.

Authors:  A Ayala; C D Herdon; D L Lehman; C A Ayala; I H Chaudry
Journal:  Blood       Date:  1996-05-15       Impact factor: 22.113

10.  Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3.

Authors:  M Miura; H Zhu; R Rotello; E A Hartwieg; J Yuan
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.